Compliance information - AIM Rule 26

The following information is disclosed in accordance with Rule 26 of the AIM Rules (February 2007), “Each AIM company must from admission maintain a website on which the following information should be available, free of charge”:

A description of its business and, where it is an investing company, its investing strategy;
Please click on the link below for a description of the business.
About Neuropharm

Last Updated: 16 Aug 2007

The names of its directors and brief biographical details of each, as would normally be included in an admission document;
A description of the responsibilities of the members of the board of directors and details of any committees of the board of directors and their responsibilities;
Please click on the link below for the names of Neuropharm Group plc’s directors, their brief biographical details, description of responsibilities and membership of any committees.
Board of Directors

Last Updated: 2 Oct 2008

Its country of incorporation and main country of operation;
Neuropharm Group plc is incorporated in England (Registration Number 5983736), which is also its main country of operation.

Last Updated: 16 Aug 2007

Where the AIM company is not incorporated in the UK, a statement that the rights of shareholders may be different from the rights of shareholders in a UK incorporated company;
The company is incorporated in the UK.

Its current constitutional documents (e.g. its articles of association);
Please click on the link below for Neuropharm Group plc’s current constitutional documents.
Corporate Governance

Last Updated: 16 Aug 2007

Details of any other exchanges or trading platforms on which the AIM company has applied or agreed to have any of its securities (including its AIM securities) admitted or traded;
The company is not listed on any other exchanges or trading platforms.

The number of AIM securities in issue (noting any held as treasury shares) and, insofar as it is aware, the percentage of AIM securities that is not in public hands together with the identity and percentage holdings of its significant shareholders;
Please click on the link below for details of the number of securities in issue, together with the identity and percentage holdings of our significant shareholders.
Significant shareholders

Last Updated: 03 Sep 2008

Details of any restrictions on the transfer of its AIM securities;
There are no restrictions on the transfer of securities.

Its most recent annual report published pusuant to rule 19 and all half-yearly, quarterly or similar reports published since the last annual report pursuant to rule 18;
Annual & Interim reports

Last Updated: 21 Oct 2008

All notifications the AIM company has made in the past 12 months;
Regulatory announcements

Its most recent admission document together with any circulars or similar publications sent to shareholders within the past 12 months;
Admission Document PDF - (736.8KB)

Last Updated: 16 Aug 2007

Details of its nominated adviser and other key advisers (as might normally be found in an admission document).
Please click on the link below for details of the company’s Nominated Advisor and other key advisors.
Advisors

Last Updated: 23 Sep 2008